Want to join the conversation?
$EXR reported that is 2Q16 adjusted FFO per share of $0.94 met the high end of its guidance range. The company's top performing markets including Atlanta, Tampa and most of the California, all experienced double-digit revenue growth. Slower markets like Chicago, Denver, Memphis, and Washington D.C. still had positive revenue growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?